Immunovant Inc (NASDAQ:IMVT)
| 20.38 Delayed Data As of Sep 22 |  -0.87 / -4.09%Today’s Change | 4.26 Today|||52-Week Range 25.13 | +14.82% Year-to-Date |
Latest IMVT News | Press Releases
No recent news for Immunovant Inc.
Today’s Trading
| Previous close | 21.25 |
| Today’s open | 21.32 |
| Day’s range | 20.11 - 21.51 |
| Volume | 112,380 |
| Average volume (3 months) | 1,170,377 |
| Market cap | $2.7B |
Data as of 4:00pm ET, 09/22/2023
Growth & Valuation
| Earnings growth (last year) | -19.95% |
| Earnings growth (this year) | -4.07% |
| Earnings growth (next 5 years) | -27.70% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 7.33 |
Competitors
Data as of 4:00pm ET, 09/22/2023
Financials
| Next reporting date | November 3, 2023 |
| EPS forecast (this quarter) | -$0.45 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$211.0M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
